Schedule 13G ownership disclosure

MATINAS BIOPHARMA HLDGS INC

Security class unavailable · CUSIP: 576810105

Event date: 2017-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
4,900,000
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-17-000601
Form type
SC 13G
Filer
Lorenzo Jennifer
CIK
CIK 1697285
Filed
Jul 03, 2017
Reporting period
Jun 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub